Caprolisin

Caprolisin may be available in the countries listed below.

Ingredient matches for Caprolisin

Aminocaproic Acid

Aminocaproic Acid is reported as an ingredient of Caprolisin in the following countries:

• Bangladesh

International Drug Name Search

BBDent

BBDent may be available in the countries listed below.

Ingredient matches for BBDent

Benzocaine

Benzocaine is reported as an ingredient of BBDent in the following countries:

• Chile


• Peru

International Drug Name Search

Kemicetin

Kemicetin may be available in the countries listed below.

Ingredient matches for Kemicetin

Chloramphenicol

Chloramphenicol is reported as an ingredient of Kemicetin in the following countries:

• Austria


• Ethiopia

International Drug Name Search

Glimaryl

Glimaryl may be available in the countries listed below.

Ingredient matches for Glimaryl

Glimepiride

Glimepiride is reported as an ingredient of Glimaryl in the following countries:

• Taiwan

International Drug Name Search

Mirtazapina Sandoz

Mirtazapina Sandoz may be available in the countries listed below.

Ingredient matches for Mirtazapina Sandoz

Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapina Sandoz in the following countries:

• Italy


• Portugal


• Spain

International Drug Name Search

Ocupress

Generic Name: carteolol ophthalmic (kar TEE oh lol off THAL mik)

Brand Names: Ocupress

What is Ocupress (carteolol ophthalmic)?

Carteolol is a beta-blocker that reduces pressure inside the eye.

Carteolol ophthalmic (for the eyes) is used to treat open-angle glaucoma and other causes of high pressure inside the eye.

Carteolol ophthalmic may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about Ocupress (carteolol ophthalmic)?

Do not use this medication if you are allergic to carteolol, or if you have asthma, or severe chronic obstructive pulmonary disease (COPD), or a heart condition called "AV block."

Before using this medication, tell your doctor if you have breathing problems such as bronchitis or emphysema, a history of heart disease or congestive heart failure, diabetes, history of stroke, blood clot, or circulation problems, a thyroid disorder, or a muscle disorder such as myasthenia gravis.

Do not allow the dropper to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.

Carteolol ophthalmic is sometimes given together with other eye medications to treat glaucoma. Do not use any other eye medication unless your doctor has prescribed it for you. If you use another eye medication, use it at least 10 minutes before or after using carteolol ophthalmic. Do not use the medications at the same time.

Carteolol ophthalmic can cause blurred vision. Be careful if you drive or do anything that requires you to be able to see clearly. Do not use this medication while you are wearing contact lenses. Carteolol ophthalmic may contain a preservative that can be absorbed by soft contact lenses. Wait at least 15 minutes after using carteolol before putting your contact lenses in.

What should I discuss with my healthcare provider before using Ocupress (carteolol ophthalmic)?

Do not use this medication if you are allergic to carteolol, or if you have:

• 
  

  asthma, or severe chronic obstructive pulmonary disease (COPD);

  
  


• 
  

  slow heartbeats; or

  
  


• 
  

  a heart condition called "AV block."

  
  

If you have any of these other conditions, you may need a dose adjustment or special tests to safely use this medication:

• 
  

  breathing problems such as bronchitis or emphysema;

  
  


• 
  

  a history of heart disease or congestive heart failure;

  
  


• 
  

  diabetes;

  
  


• 
  

  history of stroke, blood clot, or circulation problems;

  
  


• 
  

  a thyroid disorder; or

  
  


• 
  

  a muscle disorder such as myasthenia gravis.

  
  

FDA pregnancy category C. It is not known whether carteolol ophthalmic is harmful to an unborn baby. Before using this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether carteolol passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use Ocupress (carteolol ophthalmic)?

Use carteolol ophthalmic exactly as it was prescribed for you. Do not use the medication in larger amounts, or use it for longer than recommended by your doctor. Follow the instructions on your prescription label.

Wash your hands before using the eye drops. Do not use this medication while you are wearing contact lenses. Carteolol ophthalmic may contain a preservative that can be absorbed by soft contact lenses. Wait at least 15 minutes after using carteolol before putting your contact lenses in.

To apply the eye drops:

• 
  

  Tilt your head back slightly and pull down your lower eyelid. Hold the dropper above the eye with the dropper tip down. Look up and away from the dropper as you squeeze out a drop, then close your eye.

  
  


• 
  

  Gently press your finger to the inside corner of the eye (near your nose) for about 1 minute to keep the liquid from draining into your tear duct. If you use more than one drop in the same eye, wait about 5 minutes before putting in the next drop.

  
  


• 
  

  Do not allow the dropper tip to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.

  
  

Do not use the eye drops if the liquid has changed colors or has particles in it. Call your doctor for a new prescription.

Tell your doctor right away if you have any eye injury or infection. If you have any type of surgery, including eye surgery, tell the surgeon ahead of time that you are using carteolol ophthalmic. You may need to stop using the medicine for a short time. Store this medication at room temperature away from moisture, heat, and light. Keep the bottle tightly closed when not in use.

What happens if I miss a dose?

Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include slow heart rate, wheezing, feeling short of breath, swelling, rapid weight gain, or fainting.

What should I avoid while using Ocupress (carteolol ophthalmic)?

Carteolol ophthalmic can cause blurred vision. Be careful if you drive or do anything that requires you to be able to see clearly.

Carteolol ophthalmic is sometimes given together with other eye medications to treat glaucoma. Do not use any other eye medication unless your doctor has prescribed it for you. If you use another eye medication, use it at least 10 minutes before or after using carteolol ophthalmic. Do not use the medications at the same time.

Ocupress (carteolol ophthalmic) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have any of these serious side effects:

• 
  

  severe swelling, itching, burning, redness, pain, or discomfort in or around your eye;

  
  


• 
  

  drainage, crusting, or oozing of your eyes or eyelids;

  
  


• 
  

  bronchospasm (wheezing, chest tightness, trouble breathing);

  
  


• 
  

  slow heart rate, weak pulse, fainting, slow breathing (breathing may stop);

  
  


• 
  

  fast or pounding heartbeats;

  
  


• 
  

  feeling short of breath, even with mild exertion; or

  
  


• 
  

  swelling, rapid weight gain.

  
  

Less serious side effects may include:

• 
  

  mild burning, stinging, itching, or watering of your eyes;

  
  


• 
  

  blurred or cloudy vision;

  
  


• 
  

  mildly swollen or puffy eyes;

  
  


• 
  

  increased sensitivity of your eyes to light;

  
  


• 
  

  trouble seeing at night;

  
  


• 
  

  droopy eyelids;

  
  


• 
  

  headache, dizziness, depression ;

  
  


• 
  

  muscle weakness;

  
  


• 
  

  sleep problems (insomnia);

  
  


• 
  

  stuffy nose; or

  
  


• 
  

  nausea, altered sense of taste.

  
  

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Ocupress (carteolol ophthalmic)?

Before using carteolol ophthalmic, tell your doctor if you are using any of the following drugs:

• 
  

  oral carteolol (Blocadren);

  
  


• 
  

  digoxin (digitalis, Lanoxin);

  
  


• 
  

  reserpine;

  
  


• 
  

  insulin or diabetes medications you take by mouth;

  
  


• 
  

  any other beta-blocker such as atenolol (Tenormin), bisoprolol (Zebeta), labetalol (Normodyne, Trandate), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), timolol (Blocadren), and others;

  
  


• 
  

  a calcium channel blocker such as amlodipine (Norvasc), diltiazem (Tiazac, Cartia, Cardizem), felodipine (Plendil), nifedipine (Nifedical, Procardia, Adalat), verapamil (Calan, Covera, Isoptin, Verelan); or

  
  


• 
  

  medicines to treat psychiatric disorders, such as chlorpromazine (Thorazine), haloperidol (Haldol), mesoridazine (Serentil), or thioridazine (Mellaril).

  
  

This list is not complete and there may be other drugs that can interact with carteolol ophthalmic. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

More Ocupress resources

• Ocupress Side Effects (in more detail)
• Ocupress Dosage
• Ocupress Use in Pregnancy & Breastfeeding
• Ocupress Drug Interactions
• Ocupress Support Group
• 0 Reviews for Ocupress - Add your own review/rating

• Ocupress Prescribing Information (FDA)


• Ocupress Advanced Consumer (Micromedex) - Includes Dosage Information

Compare Ocupress with other medications

• Glaucoma, Open Angle
• Intraocular Hypertension

Where can I get more information?

• Your pharmacist can provide more information about carteolol ophthalmic.

See also: Ocupress side effects (in more detail)

AK-Fluor

AK-Fluor is a brand name of fluorescein, approved by the FDA in the following formulation(s):

AK-FLUOR 10% (fluorescein sodium - injectable; intravenous)

• 
  Manufacturer: AKORN
  
  Approval date: August 8, 2008
  
  Strength(s): EQ 500MG BASE/5ML (EQ 100MG BASE/ML) ^[AP]

Has a generic version of AK-Fluor been approved?

No. There is currently no therapeutically equivalent version of AK-Fluor available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of AK-Fluor. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with AK-Fluor.

See also...

Terbinafine Zydus

Terbinafine Zydus may be available in the countries listed below.

Ingredient matches for Terbinafine Zydus

Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbinafine Zydus in the following countries:

• France

International Drug Name Search

Enalapril HCT-1a Pharma

Enalapril HCT-1a Pharma may be available in the countries listed below.

Ingredient matches for Enalapril HCT-1a Pharma

Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril HCT-1a Pharma in the following countries:

• Hungary

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Enalapril HCT-1a Pharma in the following countries:

• Hungary

International Drug Name Search

Amisol

Amisol may be available in the countries listed below.

Ingredient matches for Amisol

Clobetasol

Clobetasol is reported as an ingredient of Amisol in the following countries:

• Singapore

International Drug Name Search

Topiramat-Actavis

Topiramat-Actavis may be available in the countries listed below.

Ingredient matches for Topiramat-Actavis

Topiramate

Topiramate is reported as an ingredient of Topiramat-Actavis in the following countries:

• Germany


• Sweden


• Switzerland

International Drug Name Search

Cameloc

Cameloc may be available in the countries listed below.

Ingredient matches for Cameloc

Meloxicam

Meloxicam is reported as an ingredient of Cameloc in the following countries:

• Indonesia

International Drug Name Search

Iriflexine

Iriflexine may be available in the countries listed below.

Ingredient matches for Iriflexine

Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Iriflexine in the following countries:

• Greece

International Drug Name Search

Cervical Polyps Medications

There are currently no drugs listed for "Cervical Polyps".

Definition of Cervical Polyps: Cervical polyps are fingerlike growths on the lower part of the uterus that connects with the vagina (cervix).

Learn more about Cervical Polyps

Medical Encyclopedia:

• Cervical polyps

Harvard Health Guide:

• Symptoms and treatment for Cervical Polyps

Drug List:

Florak

Florak may be available in the countries listed below.

Ingredient matches for Florak

Fluoxetine

Fluoxetine is reported as an ingredient of Florak in the following countries:

• Turkey

International Drug Name Search

Tocline

Tocline may be available in the countries listed below.

Ingredient matches for Tocline

Tibolone

Tibolone is reported as an ingredient of Tocline in the following countries:

• Argentina

International Drug Name Search

Captopril Apotex

Captopril Apotex may be available in the countries listed below.

Ingredient matches for Captopril Apotex

Captopril

Captopril is reported as an ingredient of Captopril Apotex in the following countries:

• Belgium

International Drug Name Search

Tronothane

In the US, Tronothane is a member of the drug class topical anesthetics and is used to treat Anal Itching, Hemorrhoids and Pain.

Ingredient matches for Tronothane

Pramocaine

Pramocaine hydrochloride (a derivative of Pramocaine) is reported as an ingredient of Tronothane in the following countries:

• France


• United States

International Drug Name Search

Tamoxifen-Eurogenerics

Tamoxifen-Eurogenerics may be available in the countries listed below.

Ingredient matches for Tamoxifen-Eurogenerics

Tamoxifen

Tamoxifen is reported as an ingredient of Tamoxifen-Eurogenerics in the following countries:

• Luxembourg

International Drug Name Search

Scabexyl

Scabexyl may be available in the countries listed below.

Ingredient matches for Scabexyl

Lindane

Lindane is reported as an ingredient of Scabexyl in the following countries:

• Panama

International Drug Name Search

Fendiprazol

Fendiprazol may be available in the countries listed below.

Ingredient matches for Fendiprazol

Omeprazole

Omeprazole is reported as an ingredient of Fendiprazol in the following countries:

• Argentina


• Peru

Omeprazole sodium salt (a derivative of Omeprazole) is reported as an ingredient of Fendiprazol in the following countries:

• Argentina

International Drug Name Search

Curacil

Curacil may be available in the countries listed below.

Ingredient matches for Curacil

Fluorouracil

Fluorouracil is reported as an ingredient of Curacil in the following countries:

• Indonesia

International Drug Name Search

BSS Plus Sterile Irrigating Solution

Dosage Form: ophthalmic solution
BSS PLUS®

STERILE INTRAOCULAR IRRIGATING SOLUTION

(balanced salt solution enriched with bicarbonate, dextrose, and glutathione)

DESCRIPTION SECTION

BSS PLUS® is a sterile intraocular irrigating solution for use during all intraocular surgical procedures, including those requiring a relatively long intraocular perfusion time (e.g., pars plana vitrectomy, phacoemulsification, extracapsular cataract extraction/lens aspiration, anterior segment reconstruction, etc.). The solution does not contain a preservative and should be prepared just prior to use in surgery.


Part I: Part I is a sterile 240 mL solution in a 250 mL single-dose bottle to which the Part II concentrate is added. Each mL of Part I contains: sodium chloride 7.44 mg, potassium chloride 0.395 mg, dibasic sodium phosphate 0.433 mg, sodium bicarbonate 2.19 mg, hydrochloric acid and/or sodium hydroxide (to adjust pH), in water for injection.


Part II: Part II is a sterile concentrate in a 10 mL single-dose vial for addition to Part I. Each mL of Part II contains: calcium chloride dihydrate 3.85 mg, magnesium chloride hexahydrate 5 mg, dextrose 23 mg, glutathione disulfide (oxidized glutathione) 4.6 mg, in water for injection.


After addition of BSS PLUS Part II to the Part I bottle, each mL of the reconstituted product contains: sodium chloride 7.14 mg, potassium chloride 0.38 mg, calcium chloride dihydrate 0.154 mg, magnesium chloride hexahydrate 0.2 mg, dibasic sodium phosphate 0.42 mg, sodium bicarbonate 2.1 mg, dextrose 0.92 mg, glutathione disulfide (oxidized glutathione) 0.184 mg, hydrochloric acid and/or sodium hydroxide (to adjust pH), in water for injection.


The reconstituted product has a pH of approximately 7.4. Osmolality is approximately 305 mOsm.

CLINICAL PHARMACOLOGY SECTION

None of the components of BSS PLUS are foreign to the eye, and BSS PLUS has no pharmacological action. Human perfused cornea studies have shown BSS PLUS to be an effective irrigation solution for providing corneal detumescence and maintaining corneal endothelial integrity during intraocular perfusion. An in vivo study in rabbits has shown that BSS PLUS is more suitable than normal saline or Balanced Salt Solution for intravitreal irrigation because BSS PLUS contains the appropriate bicarbonate, pH, and ionic composition necessary for the maintenance of normal retinal electrical activity. Human in vivo studies have demonstrated BSS PLUS to be safe and effective when used during surgical procedures such as pars plana vitrectomy, phacoemulsification, cataract extraction/lens aspiration, anterior segment reconstruction. No differences have been observed between adults and pediatric patients following use of this drug product.

INDICATIONS & USAGE SECTION

BSS PLUS is indicated for use as an intraocular irrigating solution during intraocular surgical procedures involving perfusion of the eye.

CONTRAINDICATIONS SECTION

There are no specific contraindications to the use of BSS PLUS; however, contraindications for the surgical procedure during which BSS PLUS is to be used should be strictly adhered to.

WARNINGS SECTION

For IRRIGATION during ophthalmic surgery only. Not for injection or intravenous infusion. Do not use unless product is clear, seal is intact, vacuum is present and container is undamaged. Do not use if product is discolored or contains a precipitate.

PRECAUTIONS SECTION

DO NOT USE BSS PLUS UNTIL PART I IS FULLY RECONSTITUTED WITH PART II. Discard unused contents. BSS PLUS does not contain a preservative; therefore, do not use this container for more than one patient. Do not use additives other than BSS PLUS Concentrate Part II (10 mL) with this product. Tissue damage could result if other drugs are added to product. DISCARD ANY UNUSED PORTION SIX HOURS AFTER PREPARATION. Studies suggest that intraocular irrigating solutions which are iso-osmotic with normal aqueous fluids should be used with caution in diabetic patients undergoing vitrectomy since intraoperative lens changes have been observed.


There have been reports of corneal clouding or edema following ocular surgery in which BSS PLUS was used as an irrigating solution. As in all surgical procedures appropriate measures should be taken to minimize trauma to the cornea and other ocular tissues.


Preparation: Reconstitute BSS PLUS® Intraocular Irrigating Solution just prior to use in surgery. Follow the same strict aseptic procedures in the reconstitution of BSS PLUS as is used for intravenous additives. Remove the blue flip-off seal from the BSS PLUS Part I (240 mL) bottle. Remove the blue flip-off seal from the BSS PLUS Part II (10 mL) vial. Clean and disinfect the rubber stoppers on both containers by using sterile alcohol wipes. Transfer the contents of the Part II vial to the Part I bottle using a BSS PLUS Vacuum Transfer Device (provided). An alternative method of solution transfer may be accomplished by using a 10 mL syringe to remove the Part II solution from the vial and transferring exactly 10 mL to the Part I container through the outer target area of the rubber stopper. An excess volume of Part II is provided in each vial. Gently agitate the contents to mix the solution. Place a sterile cap on the bottle. Remove the tear-off portion of the label. Record the time and date of reconstitution and the patient's name on the bottle label.

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

ADVERSE REACTIONS SECTION

Postoperative inflammatory reactions as well as incidents of corneal edema and corneal decompensation have been reported. Their relationship to the use of BSS PLUS has not been established.

OVERDOSAGE SECTION

The solution has no pharmacological action and thus no potential for overdosage. However, as with any intraocular surgical procedure, the duration of intraocular manipulation should be kept to a minimum.

DOSAGE & ADMINISTRATION SECTION

The solution should be used according to the standard technique employed by the operating surgeon. Use an administration set with an air-inlet in the plastic spike since the bottle does not contain a separate airway tube. Follow the directions for the particular administration set to be used. Insert the spike aseptically into the bottle through the center target area of the rubber stopper. Allow the fluid to flow to remove air from the tubing before intraocular irrigation begins. If a second bottle is necessary to complete the surgical procedure, ensure that the vacuum is vented from the second bottle BEFORE attachment to the administration set.

HOW SUPPLIED SECTION

BSS PLUS is supplied in two packages for reconstitution prior to use: a 250 mL glass bottle containing 240 mL (Part I) and a 10 mL glass vial (Part II); both using grey butyl stoppers and aluminum seals with polypropylene flip-off caps. See the PRECAUTIONS section regarding reconstitution of the solution.


NDC 0065-0800-25.


Storage: Store Part I and Part II at 2° - 25°C (36° - 77°F). DO NOT FREEZE. Discard prepared solution after six hours.


Rx Only

Alcon Laboratories, Inc.

Fort Worth, Texas 76134 USA

©2002-2003 Alcon, Inc.

340232-0803

RECONSTITUTION INSTRUCTIONS


DIRECTIONS: Use Aseptic Technique

1. Remove the blue flip-off seal from the BSS PLUS® Part I (240 mL) bottle. Remove the blue flip-off seal from the BSS PLUS Part II (10 mL) vial. Prepare the stoppers on both parts by using sterile alcohol wipes.


2. Peel open a BSS PLUS Vacuum Transfer Device package (supplied) and remove the sterile transfer spike.  NOTE: This device is vented permitting air to enter vial during solution transfer, thereby preventing the creation of a vacuum inside the vial. An air-inlet filter is provided to protect the system. Do not remove the air-inlet filter.


3. Remove protector from the white plastic piercing pin.


4. Firmly grasp device from behind the flange and insert the white plastic piercing pin into the upright rubber stopper of the BSS PLUS Part II (10 mL) vial.


5. Remove guard from filter needle. Firmly grasp vial in the palm of one hand and with thumb and index finger, hold plastic flange against top of vial.


6. 
   

   Invert vial and immediately insert filter needle into the outer target of the rubber stopper of the BSS PLUS Part I (240 mL) bottle. (See illustration.)

   
   


7. 
   

   Fluid will automatically transfer from the vial into the large vacuum bottle unless filter becomes occluded or loss of vacuum occurs. NOTE: An excess amount of BSS PLUS Part II is provided in each vial. A non-transferred solution residual of approximately 0.1 mL can be expected to remain in the vial.

   
   


8. Immediately remove needle from the BSS PLUS® Part I container and discard it after solution transfer has been completed.


9. Place a sterile safety cap over the rubber stopper of Part I if the solution is not going to be used immediately. Mix the solution gently until uniform. Peel off the right-hand side of Part I bottle label (fully reconstituted BSS PLUS Solution). Record the patient’s name and the date and time of reconstitution. BSS PLUS Solution is now ready for use.

CAUTION: Reconstituted BSS PLUS Solution must be used within six hours of mixing. Discard any solution which has aged beyond that time. Never use the same bottle of BSS PLUS Solution on more than one patient.


Alternative Transfer Method

If preferred, the contents of the BSS PLUS Part II component may be aspirated with an 18-gauge cannula attached to a 10 mL syringe and then transferred into the Part I bottle.

Alcon Laboratories, Inc.

Fort Worth, Texas 76134 USA

Printed in USA

Revised: August 2003

PRINCIPAL DISPLAY PANEL

NDC 0065-0800-25         250 mL


BSS PLUS®          Single Patient Use

STERILE INTRAOCULAR IRRIGATION SOLUTION

(balanced salt solution enriched with bicarbonate, dextrose, and glutathione)


After addition of BSS Plus® - Part II (10 mL), each mL contains: sodium chloride 7.14 mg, potassium chloride 0.38 mg, calcium chloride dihydrate 0.154 mg, magnesium chloride 0.92 mg, glutathione disulfide (oxidized glutathione) 0.184 mg, hydrochloric acid and/or sodium hydroxide (to adjust pH), in water for injection.

pH Approx. 7.4 - Osmolality Approx. 305 mOsm/kg

Rx Only

WARNINGS: FOR IRRIGATION DURING OPHTHALMIC SURGERY ONLY.  NOT FOR INJECTION OR INTRAVENOUS INFUSION.  DO NOT USE UNLESS PRODUCT IS CLEAR, SEAL IS INTACT, VACUUM IS PRESENT AND CONTAINER IS UNDAMAGED.  DO NOT USE IF PRODUCT IS DISCOLORED OR CONTAINS A PRECIPITATE. PRECAUTIONS:  DO NOT USE BSS PLUS UNTIL PART I IS FULLY RECONSTITUTED WITH PART II.

DO NOT USE ADDITIVES OTHER THAN BSS PLUS CONCENTRATE PART II (10 ML) WITH THIS PRODUCT.

DISCARD UNUSED CONTENTS SIX HOURS AFTER PREPARATION.

TISSUE DAMAGE COULD RESULT IF OTHER DRUGS ARE ADDED TO PRODUCT.

DO NOT USE THIS CONTAINER FOR MORE THAN ONE PATIENT.

Reconstitute just prior to use in surgery.


Printed in USA


Alcon®

Alcon Laboratories, Inc.

Fort Worth, Texas  76134 USA

BSS PLUS   balanced salt solution enriched with bicarbonate, dextrose, and glutathione  kit

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0065-0800

Packaging # NDC Package Description Multilevel Packaging 1 0065-0800-25 1 KIT In 1 PACKAGE None

QUANTITY OF PARTS Part # Package Quantity Total Product Quantity Part 1 1 BOTTLE   240 mL Part 2 1 VIAL, SINGLE-DOSE   10 mL

Part 1 of 2 PART I   sodium chloride, potassium chloride, dibasic sodium phosphate, sodium bicarbonate  solution

Product Information       Route of Administration OPHTHALMIC DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Sodium Chloride (Sodium Cation) Sodium Chloride 7.44 mg  in 1 mL Potassium Chloride (Potassium Cation) Potassium Chloride 0.395 mg  in 1 mL Sodium Phosphate, Dibasic (Sodium Cation) Sodium Phosphate, Dibasic 0.433 mg  in 1 mL Sodium Bicarbonate (Sodium Cation) Sodium Bicarbonate 2.19 mg  in 1 mL

Inactive Ingredients Ingredient Name Strength Hydrochloric Acid   Sodium Hydroxide

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 240 mL In 1 BOTTLE None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA018469 06/28/1982

Part 2 of 2 PART II   calcium chloride dihydrate, magnesium chloride hexahydrate, dextrose, glutathione disulfide  concentrate

Product Information       Route of Administration OPHTHALMIC DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Calcium Chloride (Calcium Cation) Calcium Chloride 3.85 mg  in 1 mL Magnesium Chloride (Magnesium Cation) Magnesium Chloride 5 mg  in 1 mL Dextrose (Dextrose) Dextrose 23 mg  in 1 mL Oxiglutatione (Glutathione) Oxiglutatione 4.6 mg  in 1 mL

Inactive Ingredients Ingredient Name Strength Water

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 10 mL In 1 VIAL, SINGLE-DOSE None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA018469 06/28/1982

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NDA	NDA018469	06/28/1982

Labeler - Alcon Laboratories, Inc. (008018525)

Registrant - Alcon Laboratories, Inc. (008018525)

Establishment
Name	Address	ID/FEI	Operations
Alcon Laboratories, Inc.		008018525	MANUFACTURE

Revised: 12/2011Alcon Laboratories, Inc.

AVC

In the US, AVC (sulfanilamide topical) is a member of the drug class vaginal anti-infectives and is used to treat Vaginal Yeast Infection.

US matches:

• AVC

Ingredient matches for AVC

Sulfanilamide

Sulfanilamide is reported as an ingredient of AVC in the following countries:

• United States

International Drug Name Search

Doxitin

Doxitin may be available in the countries listed below.

Ingredient matches for Doxitin

Doxycycline

Doxycycline is reported as an ingredient of Doxitin in the following countries:

• Latvia


• Lithuania

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxitin in the following countries:

• Estonia

International Drug Name Search

Terasep

Terasep may be available in the countries listed below.

Ingredient matches for Terasep

Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Terasep in the following countries:

• Argentina

International Drug Name Search

Taipidium

Taipidium may be available in the countries listed below.

Ingredient matches for Taipidium

Timepidium Bromide

Timepidium Bromide is reported as an ingredient of Taipidium in the following countries:

• Japan

International Drug Name Search

Fénoprofène

Fénoprofène may be available in the countries listed below.

Ingredient matches for Fénoprofène

Fenoprofen

Fénoprofène (DCF) is known as Fenoprofen in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Sinekin

Sinekin may be available in the countries listed below.

Ingredient matches for Sinekin

Biperiden

Biperiden hydrochloride (a derivative of Biperiden) is reported as an ingredient of Sinekin in the following countries:

• Argentina

International Drug Name Search

Toviaz

In the US, Toviaz (fesoterodine systemic) is a member of the drug class urinary antispasmodics and is used to treat Overactive Bladder and Urinary Incontinence.

US matches:

• Toviaz

UK matches:

• TOVIAZ 4 mg prolonged-release tablets & TOVIAZ 8 mg prolonged-release tablets (SPC)

Ingredient matches for Toviaz

Fesoterodine

Fesoterodine is reported as an ingredient of Toviaz in the following countries:

• Ireland

Fesoterodine fumarate (a derivative of Fesoterodine) is reported as an ingredient of Toviaz in the following countries:

• Belgium


• Denmark


• Germany


• Netherlands


• Norway


• Slovakia


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Topcid

Topcid may be available in the countries listed below.

Ingredient matches for Topcid

Famotidine

Famotidine is reported as an ingredient of Topcid in the following countries:

• India

International Drug Name Search

Vitamin B6-Hevert

Vitamin B6-Hevert may be available in the countries listed below.

Ingredient matches for Vitamin B6-Hevert

Pyridoxine

Pyridoxine hydrochloride (a derivative of Pyridoxine) is reported as an ingredient of Vitamin B6-Hevert in the following countries:

• Germany

International Drug Name Search

Dorixyl

Dorixyl may be available in the countries listed below.

Ingredient matches for Dorixyl

Clonixin

Clonixin is reported as an ingredient of Dorixyl in the following countries:

• Peru

International Drug Name Search

TRH Ferring

TRH Ferring may be available in the countries listed below.

Ingredient matches for TRH Ferring

Protirelin

Protirelin is reported as an ingredient of TRH Ferring in the following countries:

• Argentina


• Germany


• Turkey

International Drug Name Search

Silymarin-CT

Silymarin-CT may be available in the countries listed below.

Ingredient matches for Silymarin-CT

Silibinin

Silibinin is reported as an ingredient of Silymarin-CT in the following countries:

• Germany

International Drug Name Search

Clofedanol

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R05DB10

CAS registry number (Chemical Abstracts Service)

0000791-35-5

Chemical Formula

C17-H20-Cl-N-O

Molecular Weight

289

Therapeutic Category

Cough suppressant

Chemical Name

Benzenemethanol, 2-chloro-α-[2-(dimethylamino)ethyl]-α-phenyl-

Foreign Names

• Clofedanolum (Latin)
• Clofedanol (German)
• Clofédanol (French)
• Clofedanol (Spanish)

Generic Names

• Chlophedianol (OS: BAN)
• Clofedanol (OS: BAN)
• Clofédanol (OS: DCF)
• Clofedanolo (OS: DCIT)
• Bayer 186 (IS)
• Chlophedianol Hydrochloride (OS: USAN)
• Clofedanol Hydrochloride (OS: BANM)
• Bayer B 186 (IS)
• SL 501 (IS)
• Clofedanol Hydrochloride (PH: JP XV)

Brand Names

• Coldrin
  Nippon Shinyaku, Japan



• Ulone
  Graceway Pharmaceuticals, Canada

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Cholit-Ursan

Cholit-Ursan may be available in the countries listed below.

Ingredient matches for Cholit-Ursan

Ursodeoxycholic Acid

Ursodeoxycholic Acid is reported as an ingredient of Cholit-Ursan in the following countries:

• Germany

International Drug Name Search

Broncholit

Broncholit may be available in the countries listed below.

Ingredient matches for Broncholit

Carbocisteine

Carbocisteine is reported as an ingredient of Broncholit in the following countries:

• Indonesia

International Drug Name Search

Goutmalon

Goutmalon may be available in the countries listed below.

Ingredient matches for Goutmalon

Benzbromarone

Benzbromarone is reported as an ingredient of Goutmalon in the following countries:

• Japan

International Drug Name Search

Pulna

Pulna may be available in the countries listed below.

Ingredient matches for Pulna

Ethambutol

Ethambutol is reported as an ingredient of Pulna in the following countries:

• Indonesia

Isoniazid

Isoniazid is reported as an ingredient of Pulna in the following countries:

• Indonesia

Ketoconazole

Ketoconazole is reported as an ingredient of Pulna in the following countries:

• Japan

Pyridoxine

Pyridoxine is reported as an ingredient of Pulna in the following countries:

• Indonesia

International Drug Name Search

Diamide

Diamide may be available in the countries listed below.

Ingredient matches for Diamide

Chlorpropamide

Chlorpropamide is reported as an ingredient of Diamide in the following countries:

• Sri Lanka

Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Diamide in the following countries:

• New Zealand

International Drug Name Search

Cisaprida

Cisaprida may be available in the countries listed below.

Ingredient matches for Cisaprida

Cisapride

Cisapride is reported as an ingredient of Cisaprida in the following countries:

• Chile

International Drug Name Search

Depreotide

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0161982-62-3

Chemical Formula

C65-H96-N16-O12-S2

Molecular Weight

1357

Therapeutic Category

Radiodiagnostic agent

Chemical Name

Cyclo(L-homocysteinyl-N-methyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl), (1->1')-sulfide with 3-(2-mercaptoacetamido)-L-alanyl-L-lysyl-L-cysteinyl-L-lysinamide (WHO)

Foreign Names

• Depreotidum (Latin)
• Depreotid (German)
• Dépréotide (French)
• Depreotida (Spanish)

Generic Names

• Depreotide (OS: USAN)
• Dépréotide (OS: DCF)
• P 829 (IS: Diatide)
• [99mTc]Techneticum-Depreotid (IS)
• Tc 99m depreotide (IS)
• Tc 99m P829 (IS)
• Techneticum[99mTc]depreotide (IS)

Brand Names

• NeoSpect
  Cis Bio-F, Italy; Amersham, Spain; Amersham, France; Amersham, Greece; Amersham, Ireland; Cis Bio, Luxembourg

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Glicolic

Glicolic may be available in the countries listed below.

Ingredient matches for Glicolic

Folic Acid

Folic Acid is reported as an ingredient of Glicolic in the following countries:

• Peru

International Drug Name Search

Flosal

Flosal may be available in the countries listed below.

Ingredient matches for Flosal

Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Flosal in the following countries:

• Latvia

Salmeterol

Salmeterol is reported as an ingredient of Flosal in the following countries:

• Latvia

International Drug Name Search

Megasid

Megasid may be available in the countries listed below.

Ingredient matches for Megasid

Clarithromycin

Clarithromycin is reported as an ingredient of Megasid in the following countries:

• Turkey

International Drug Name Search

Tavegyl

Tavegyl may be available in the countries listed below.

Ingredient matches for Tavegyl

Clemastine

Clemastine is reported as an ingredient of Tavegyl in the following countries:

• Colombia


• Iceland


• Romania


• South Africa

Clemastine fumarate (a derivative of Clemastine) is reported as an ingredient of Tavegyl in the following countries:

• Bahrain


• Bulgaria


• Czech Republic


• Denmark


• Egypt


• Estonia


• Ghana


• Indonesia


• Iraq


• Japan


• Jordan


• Kenya


• Kuwait


• Latvia


• Lebanon


• Libya


• Lithuania


• Nigeria


• Philippines


• Portugal


• Qatar


• Russian Federation


• Saudi Arabia


• Slovakia


• Slovenia


• Sudan


• Sweden


• Switzerland


• Tanzania


• Turkey


• United Arab Emirates


• Yemen

International Drug Name Search

Tamoxifen aries

Tamoxifen aries may be available in the countries listed below.

Ingredient matches for Tamoxifen aries

Tamoxifen

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamoxifen aries in the following countries:

• Germany

International Drug Name Search

Diltiazem Sandoz

Diltiazem Sandoz may be available in the countries listed below.

Ingredient matches for Diltiazem Sandoz

Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Diltiazem Sandoz in the following countries:

• France


• Italy


• Spain

International Drug Name Search

Capozide 25 / 25

See also: Generic Capozide 25/15, Generic Capozide 50/15, Generic Capozide 50/25

Capozide 25/25 is a brand name of captopril/hydrochlorothiazide, approved by the FDA in the following formulation(s):

CAPOZIDE 25/25 (captopril; hydrochlorothiazide - tablet; oral)

• 
  Manufacturer: APOTHECON
  
  Approval date: October 12, 1984
  
  Strength(s): 25MG;25MG ^[RLD][AB]

Has a generic version of Capozide 25/25 been approved?

Yes. The following products are equivalent to Capozide 25/25:

CAPTOPRIL AND HYDROCHLOROTHIAZIDE (captopril; hydrochlorothiazide tablet; oral)

• 
  Manufacturer: MYLAN
  
  Approval date: December 29, 1997
  
  Strength(s): 25MG;25MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: December 29, 1997
  
  Strength(s): 25MG;25MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Capozide 25/25. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Capozide 25/25.

See also...

• Capozide 25/25 Consumer Information (Cerner Multum)
• Capozide 25/25 Advanced Consumer Information (Micromedex)
• Captopril/Hydrochlorothiazide Consumer Information (Wolters Kluwer)
• Hydrochlorothiazide and captopril Consumer Information (Cerner Multum)
• Captopril and hydrochlorothiazide Advanced Consumer Information (Micromedex)

Ausentron

Ausentron may be available in the countries listed below.

Ingredient matches for Ausentron

Clomipramine

Clomipramine is reported as an ingredient of Ausentron in the following countries:

• Chile

International Drug Name Search

Acfol

Acfol may be available in the countries listed below.

Ingredient matches for Acfol

Folic Acid

Folic Acid is reported as an ingredient of Acfol in the following countries:

• Portugal


• Spain

International Drug Name Search

Septolete Plus

Septolete Plus may be available in the countries listed below.

Ingredient matches for Septolete Plus

Benzocaine

Benzocaine is reported as an ingredient of Septolete Plus in the following countries:

• Poland

Cetylpyridinium

Cetylpyridinium chloride (a derivative of Cetylpyridinium) is reported as an ingredient of Septolete Plus in the following countries:

• Poland

Cetylpyridinium chloride monohydrate (a derivative of Cetylpyridinium) is reported as an ingredient of Septolete Plus in the following countries:

• Slovakia

International Drug Name Search

TramaHexal

TramaHexal may be available in the countries listed below.

Ingredient matches for TramaHexal

Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of TramaHexal in the following countries:

• Australia


• Poland


• South Africa

International Drug Name Search

Cabergolina Teva

Cabergolina Teva may be available in the countries listed below.

Ingredient matches for Cabergolina Teva

Cabergoline

Cabergoline is reported as an ingredient of Cabergolina Teva in the following countries:

• Italy

International Drug Name Search

Eminapyrin

Eminapyrin may be available in the countries listed below.

Ingredient matches for Eminapyrin

Sulfasalazine

Sulfasalazine is reported as an ingredient of Eminapyrin in the following countries:

• Japan

International Drug Name Search

Claritromicinã

Claritromicinã may be available in the countries listed below.

Ingredient matches for Claritromicinã

Clarithromycin

Clarithromycin is reported as an ingredient of Claritromicinã in the following countries:

• Romania

International Drug Name Search

Lincomicina MK

Lincomicina MK may be available in the countries listed below.

Ingredient matches for Lincomicina MK

Lincomycin

Lincomycin hydrochloride monohydrate (a derivative of Lincomycin) is reported as an ingredient of Lincomicina MK in the following countries:

• Colombia


• Costa Rica


• Dominican Republic


• Ecuador


• El Salvador


• Guatemala


• Honduras


• Nicaragua


• Panama

International Drug Name Search

R Pen

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for R Pen

Benzylpenicillin

Benzylpenicillin potassium (a derivative of Benzylpenicillin) is reported as an ingredient of R Pen in the following countries:

• United States

International Drug Name Search

Tractocile

Tractocile may be available in the countries listed below.

UK matches:

• Tractocile 7.5 mg/ml Concentrate for Solution for Infusion
• Tractocile 7.5 mg/ml Solution for Injection
• Tractocile 7.5 mg/ml Concentrate for Solution for Infusion (SPC)
• Tractocile 7.5 mg/ml Solution for Injection (SPC)

Ingredient matches for Tractocile

Atosiban

Atosiban is reported as an ingredient of Tractocile in the following countries:

• Argentina


• Bulgaria


• Croatia (Hrvatska)


• Mexico


• Norway


• Turkey

Atosiban acetate (a derivative of Atosiban) is reported as an ingredient of Tractocile in the following countries:

• Austria


• Bahrain


• Belgium


• Bosnia & Herzegowina


• Czech Republic


• Denmark


• Egypt


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Ireland


• Italy


• Jordan


• Kuwait


• Lebanon


• Luxembourg


• Malaysia


• Netherlands


• New Zealand


• Oman


• Poland


• Qatar


• Saudi Arabia


• Serbia


• Slovakia


• South Africa


• Sweden


• Switzerland


• Syria


• United Arab Emirates


• United Kingdom


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Noctiplon

Noctiplon may be available in the countries listed below.

Ingredient matches for Noctiplon

Zaleplon

Zaleplon is reported as an ingredient of Noctiplon in the following countries:

• Chile

International Drug Name Search

Pantosin

Pantosin may be available in the countries listed below.

Ingredient matches for Pantosin

Pantothenate

Pantethine is reported as an ingredient of Pantosin in the following countries:

• Japan

International Drug Name Search

Ondameton

Ondameton may be available in the countries listed below.

Ingredient matches for Ondameton

Ondansetron

Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Ondameton in the following countries:

• Greece

International Drug Name Search

Edictum

Edictum may be available in the countries listed below.

Ingredient matches for Edictum

Clonazepam

Clonazepam is reported as an ingredient of Edictum in the following countries:

• Argentina

International Drug Name Search

Trogine

Trogine may be available in the countries listed below.

Ingredient matches for Trogine

Lamotrigine

Lamotrigine is reported as an ingredient of Trogine in the following countries:

• Poland

International Drug Name Search

Testosterone Propionate

Testosterone Propionate may be available in the countries listed below.

Ingredient matches for Testosterone Propionate

Testosterone

Testosterone Propionate (BANM, JAN) is known as Testosterone in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
JAN	Japanese Accepted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Xylavet

Xylavet may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Xylavet

Xylazine

Xylazine is reported as an ingredient of Xylavet in the following countries:

• South Africa

International Drug Name Search

Pirobeta

Pirobeta may be available in the countries listed below.

Ingredient matches for Pirobeta

Piroxicam

Piroxicam is reported as an ingredient of Pirobeta in the following countries:

• Germany

International Drug Name Search

Felbatol

Felbatol is a brand name of felbamate, approved by the FDA in the following formulation(s):

FELBATOL (felbamate - suspension; oral)

• 
  Manufacturer: MEDA PHARMS
  
  Approval date: July 29, 1993
  
  Strength(s): 600MG/5ML ^[RLD][AB]

FELBATOL (felbamate - tablet; oral)

• 
  Manufacturer: MEDA PHARMS
  
  Approval date: July 29, 1993
  
  Strength(s): 400MG ^[AB], 600MG ^[RLD][AB]

Has a generic version of Felbatol been approved?

Yes. The following products are equivalent to Felbatol:

felbamate suspension; oral

• 
  Manufacturer: AMNEAL PHARMS
  
  Approval date: December 16, 2011
  
  Strength(s): 600MG/5ML ^[AB]

felbamate tablet; oral

• 
  Manufacturer: AMNEAL PHARMS
  
  Approval date: September 13, 2011
  
  Strength(s): 400MG ^[AB], 600MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Felbatol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Felbatol.

See also...

• Felbatol Consumer Information (Wolters Kluwer)
• Felbatol Suspension Consumer Information (Wolters Kluwer)
• Felbatol Consumer Information (Cerner Multum)
• Felbatol Advanced Consumer Information (Micromedex)
• Felbatol AHFS DI Monographs (ASHP)
• Felbamate Consumer Information (Wolters Kluwer)
• Felbamate Suspension Consumer Information (Wolters Kluwer)
• Felbamate Consumer Information (Cerner Multum)
• Felbamate Advanced Consumer Information (Micromedex)
• Felbamate AHFS DI Monographs (ASHP)

Gaseoplus

Gaseoplus may be available in the countries listed below.

Ingredient matches for Gaseoplus

Simeticone

Simeticone is reported as an ingredient of Gaseoplus in the following countries:

• Peru

International Drug Name Search

Captopril / Hydrochloorthiazide Katwijk

Captopril / Hydrochloorthiazide Katwijk may be available in the countries listed below.

Ingredient matches for Captopril / Hydrochloorthiazide Katwijk

Captopril

Captopril is reported as an ingredient of Captopril / Hydrochloorthiazide Katwijk in the following countries:

• Netherlands

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Captopril / Hydrochloorthiazide Katwijk in the following countries:

• Netherlands

International Drug Name Search

Metaptyl

Metaptyl may be available in the countries listed below.

Ingredient matches for Metaptyl

Cefoxitin

Cefoxitin sodium salt (a derivative of Cefoxitin) is reported as an ingredient of Metaptyl in the following countries:

• Greece

International Drug Name Search

Ethynodiol Diacetate

Ethynodiol Diacetate may be available in the countries listed below.

Ingredient matches for Ethynodiol Diacetate

Etynodiol

Ethynodiol Diacetate (USAN) is also known as Etynodiol (Prop.INN)

International Drug Name Search

Glossary

Prop.INN	Proposed International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Clinda-Wolff

Clinda-Wolff may be available in the countries listed below.

Ingredient matches for Clinda-Wolff

Clindamycin

Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Clinda-Wolff in the following countries:

• Germany

International Drug Name Search

Prednisona Lch

Prednisona Lch may be available in the countries listed below.

Ingredient matches for Prednisona Lch

Prednisone

Prednisone is reported as an ingredient of Prednisona Lch in the following countries:

• Peru

International Drug Name Search

Tamoxifène

Tamoxifène may be available in the countries listed below.

Ingredient matches for Tamoxifène

Tamoxifen

Tamoxifène (DCF) is known as Tamoxifen in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Glucosamina Solfato EG

Glucosamina Solfato EG may be available in the countries listed below.

Ingredient matches for Glucosamina Solfato EG

Glucosamine

Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Glucosamina Solfato EG in the following countries:

• Italy

International Drug Name Search

Lifercal

Lifercal may be available in the countries listed below.

Ingredient matches for Lifercal

Alfacalcidol

Alfacalcidol is reported as an ingredient of Lifercal in the following countries:

• Greece

International Drug Name Search

Toyofarol

Toyofarol may be available in the countries listed below.

Ingredient matches for Toyofarol

Alfacalcidol

Alfacalcidol is reported as an ingredient of Toyofarol in the following countries:

• Japan

International Drug Name Search

Vinorelbin Medac

Vinorelbin Medac may be available in the countries listed below.

Ingredient matches for Vinorelbin Medac

Vinorelbine

Vinorelbine tartrate (a derivative of Vinorelbine) is reported as an ingredient of Vinorelbin Medac in the following countries:

• Austria


• Hungary

International Drug Name Search